Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Metformin's effect on breast cancer

Dr Vuk Stambolic - Ontario Cancer Institute, Toronto, Canada
Metformin's effect on breast cancer ( Dr Vuk Stambolic - Ontario Cancer Institute, Toronto, Canada )
13 Apr 2012

Metformin to slow prostate cancer growth

Dr Anthony Joshua - Princess Margaret Hospital, Toronto, Canada
Metformin to slow prostate cancer growth ( Dr Anthony Joshua - Princess Margaret Hospital, Toronto, Canada )
13 Apr 2012

Targeted therapy for refractory Ewing’s Sarcoma tumours

Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA
Targeted therapy for refractory Ewing’s Sarcoma tumours ( Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA )
13 Apr 2012

Galeterone safe and effective against prostate cancer

Dr Bruce Montgomery - University of Washington, Seattle, USA
Galeterone safe and effective against prostate cancer ( Dr Bruce Montgomery - University of Washington, Seattle, USA )
13 Apr 2012

Selumetinib controlled recurrent low-grade serous ovarian cancer

Dr John Farley - Creighton University, Phoenix, Arizona, USA
Selumetinib controlled recurrent low-grade serous ovarian cancer ( Dr John Farley - Creighton University, Phoenix, Arizona, USA )
13 Apr 2012

Ibrutinib induces responses in aggressive lymphomas

Dr Louis Staudt - National Cancer Institute, Bethesda, Maryland, USA
Ibrutinib induces responses in aggressive lymphomas ( Dr Louis Staudt - National Cancer Institute, Bethesda, Maryland, USA )
13 Apr 2012

Hypoxia influenced tumour behaviour in prostate cancer

Dr Michael Milosevic - University of Toronto, Ontario, Canada
Hypoxia influenced tumour behaviour in prostate cancer ( Dr Michael Milosevic - University of Toronto, Ontario, Canada )
13 Apr 2012

Biomarker identified in relation to pazopanib in refractory urothelial cancer

Dr Andrea Necchi - National Cancer Institute of Milan, Italy
Biomarker identified in relation to pazopanib in refractory urothelial cancer ( Dr Andrea Necchi - National Cancer Institute of Milan, Italy )
13 Apr 2012

EGFR mutation unique to glioblastoma linked to lack of response

Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA
EGFR mutation unique to glioblastoma linked to lack of response ( Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA )
13 Apr 2012

Noninvasive imaging markers in prostate cancer

Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA
Noninvasive imaging markers in prostate cancer ( Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA )
13 Apr 2012

Effects of vitamin D on prostate cancer

Prof Reinhold Vieth - University of Toronto, Ontario, Canada
Effects of vitamin D on prostate cancer ( Prof Reinhold Vieth - University of Toronto, Ontario, Canada )
13 Apr 2012

Cancer in the developing world

Dr Tim Rebbeck - University of Pennsylvania, Philadelphia, USA
Cancer in the developing world ( Dr Tim Rebbeck - University of Pennsylvania, Philadelphia, USA )
12 Apr 2012